Undeterred by Novo Nordisk failure, scientists consider GLP-1s as Alzheimer’s prevention
More trials needed testing the drugs in people at risk of dementia, scientists say Diabetes patients on GLP-1s…
Lower prices mean more Americans can start weight-loss drugs, doctors say
Trump administration deal cuts prices for GLP-1 weight-loss drugs Medicare patients see expanded eligibility and capped costs Concerns…